Daniel G. Coit
#132,393
Most Influential Person Now
Daniel G. Coit's AcademicInfluence.com Rankings
Daniel G. Coitphilosophy Degrees
Philosophy
#6499
World Rank
#9544
Historical Rank
Logic
#3654
World Rank
#4846
Historical Rank
Download Badge
Philosophy
Why Is Daniel G. Coit Influential?
(Suggest an Edit or Addition)Daniel G. Coit's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Final version of 2009 AJCC melanoma staging and classification. (2009) (4419)
- Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. (2001) (2651)
- Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. (2001) (2315)
- Liver resection for colorectal metastases. (1997) (848)
- Clinicopathologic correlates of solitary fibrous tumors (2002) (686)
- Merkel cell carcinoma: prognosis and treatment of patients from a single institution. (2005) (683)
- Prospective Randomized Clinical Trial of the Value of Intraperitoneal Drainage After Pancreatic Resection (2001) (502)
- Lymph Node Metastasis From Soft Tissue Sarcoma in Adults Analysis of Data From a Prospective Database of 1772 Sarcoma Patients (1993) (501)
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers (2015) (461)
- Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. (1998) (443)
- A new American Joint Committee on Cancer staging system for cutaneous melanoma (2000) (428)
- An Evidence‐based Staging System for Cutaneous Melanoma 1 (2004) (420)
- Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. (2007) (413)
- Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. (2010) (389)
- Merkel cell carcinoma. Prognosis and management. (1991) (356)
- Laparoscopic Versus Open Distal Gastrectomy for Gastric Cancer: A Meta-Analysis of Randomized Controlled Trials and High-Quality Nonrandomized Studies (2012) (339)
- Long-term Survival Following Treatment of Pseudomyxoma Peritonei: An Analysis of Surgical Therapy (2005) (327)
- Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. (2011) (327)
- Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project (2017) (321)
- Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram (2010) (317)
- Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. (2008) (311)
- The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. (1996) (305)
- Management of Primary and Recurrent Soft‐tissue Sarcoma of the Retroperitoneum (1990) (294)
- Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (289)
- The role of surgery in the treatment of clinically isolated adrenal metastasis (1998) (281)
- Surgical management of Merkel cell carcinoma. (1999) (257)
- Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. (2001) (255)
- Radical surgery for gastric cancer. A review of the Japanese experience (1989) (247)
- Sentinel Lymph Node Biopsy in the Management of Patients With Primary Cutaneous Melanoma: Review of a Large Single-Institutional Experience With an Emphasis on Recurrence (2001) (236)
- Pancreatic Adenocarcinoma: The Actual 5-Year Survivors (2008) (229)
- Patterns of detection in patients with cutaneous melanoma (2000) (221)
- Adenocarcinoma of the Gastroesophageal Junction: Influence of Esophageal Resection Margin and Operative Approach on Outcome (2007) (220)
- Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. (2010) (219)
- Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. (2018) (214)
- Clinicopathological features of and risk factors for multiple primary melanomas. (2005) (212)
- The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection (2005) (211)
- A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients (2006) (206)
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma (2008) (188)
- Characterization of Micrometastatic Disease in Melanoma Sentinel Lymph Nodes by Enhanced Pathology: Recommendations for Standardizing Pathologic Analysis (2005) (188)
- Metastasis to the Adrenal Gland: The Emerging Role of Laparoscopic Surgery (2003) (180)
- Laparoscopic Versus Open Subtotal Gastrectomy for Adenocarcinoma: A Case–Control Study (2009) (177)
- Subcutaneously implanted central venous access devices in cancer patients (1997) (175)
- Cutaneous Desmoplastic Melanoma: Reappraisal of Morphologic Heterogeneity and Prognostic Factors (2004) (174)
- Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. (1991) (171)
- Merkel cell carcinoma (2001) (169)
- Sentinel Lymph Node Biopsy in Patients With Diagnostically Controversial Spitzoid Melanocytic Tumors (2002) (164)
- Recurrence and Survival in Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: Analysis of 153 Patients from a Single Institution (2011) (162)
- The Role of Abdominoperineal Resection as Surgical Therapy for Anorectal Melanoma (2006) (161)
- Melanoma, version 2.2016 clinical practice guidelines in oncology (2016) (161)
- Differences in gastric cancer survival between the U.S. and China (2015) (154)
- Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution (2011) (153)
- Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases (2013) (150)
- MET Expression and Amplification in Patients with Localized Gastric Cancer (2011) (148)
- Laparoscopic Versus Open Gastric Resections for Primary Gastrointestinal Stromal Tumors (GISTs): A Size-Matched Comparison (2011) (147)
- Hereditary diffuse gastric cancer: updated clinical practice guidelines. (2020) (145)
- Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma (2006) (142)
- Hepatic Metastases from Soft‐Tissue Sarcoma (1995) (142)
- Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma (1999) (140)
- The malignant nature of papillary and cystic neoplasm of the pancreas (1991) (138)
- Prediction of Nonsentinel Lymph Node Status in Melanoma (2003) (138)
- Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma (2004) (136)
- Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis. (2016) (136)
- Surgery for Melanoma Metastatic to the Gastrointestinal Tract (1999) (131)
- Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status (2002) (129)
- New TNM melanoma staging system: linking biology and natural history to clinical outcomes. (2003) (128)
- Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. (1998) (127)
- A Nomogram That Predicts the Presence of Sentinel Node Metastasis in Melanoma With Better Discrimination Than the American Joint Committee on CancerStaging System (2005) (127)
- Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma (2016) (126)
- Future cancer research priorities in the USA: a Lancet Oncology Commission. (2017) (125)
- Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients (2011) (123)
- Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients (2014) (122)
- A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma (2014) (122)
- A prospective evaluation of the utility of 2‐deoxy‐2‐[18F]fluoro‐D‐glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer (2012) (122)
- Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case–Control Study (2015) (121)
- Prognosis of Acral Melanoma: A Series of 281 Patients (2013) (119)
- Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines (2013) (115)
- Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database (2010) (113)
- The Diminishing Role of Surgery in the Treatment of Gastric Lymphoma (2004) (113)
- Is intraabdominal drainage necessary after pancreaticoduodenectomy? (1998) (111)
- Clinical Correlation of Endoscopic Ultrasonography with Pathologic Stage and Outcome in Patients Undergoing Curative Resection for Gastric Cancer (2007) (111)
- Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma (2001) (107)
- Impact of Obesity on Perioperative Complications and Long-term Survival of Patients with Gastric Cancer (2013) (105)
- Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma (2014) (100)
- Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. (2003) (100)
- Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis (2007) (98)
- Does Graded Histologic Response After Neoadjuvant Chemotherapy Predict Survival for Completely Resected Gastric Cancer? (2007) (98)
- A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression. (1990) (97)
- Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma (2011) (94)
- Detection of Tyrosinase mRNA by Reverse Transcription Polymerase Chain Reaction in Melanoma Sentinel Nodes (1999) (94)
- Extent of lymph node dissection in melanoma of the trunk or lower extremity. (1989) (93)
- Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas (2009) (93)
- Sentinel Lymph Node Biopsy for Patients With Cutaneous Desmoplastic Melanoma (2003) (91)
- Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. (2012) (90)
- Clinical Outcomes With Laparoscopic Stage M1, Unresected Gastric Adenocarcinoma (2006) (90)
- Direct observations of surgical wound infections at a comprehensive cancer center. (1995) (90)
- Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. (2016) (89)
- Defining Surgical Indications for Type I Gastric Carcinoid Tumor (2009) (88)
- Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. (1990) (87)
- Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival (2007) (86)
- Melanoma metastatic to stomach, small bowel, or colon. (1991) (85)
- Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy (2001) (84)
- Major amputation for advanced malignant melanoma. (1989) (84)
- Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. (1994) (84)
- Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy (2010) (81)
- Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma (2012) (80)
- NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines (2016) (79)
- High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy (2019) (79)
- Staging laparoscopy in the management of gastric cancer: a population-based analysis. (2011) (79)
- Sentinel lymph node evaluation in melanoma. (1997) (78)
- NCCN MELANOMA PRACTICE GUIDELINES (1998) (78)
- Desmoplastic small round cell tumors: Prognostic indicators and results of surgical management (1998) (78)
- Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. (2009) (77)
- Axillary dissection in melanoma. Prognostic variables in node-positive patients. (1990) (77)
- Adenocarcinoma arising within a gastric duplication cyst (1992) (77)
- Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma (2018) (76)
- Association of Positive Transection Margins with Gastric Cancer Survival and Local Recurrence (2013) (76)
- The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma (2006) (75)
- Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment☆ (2017) (74)
- Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients. (2004) (74)
- Quality of Life After Gastrectomy for Adenocarcinoma: A Prospective Cohort Study (2013) (73)
- Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome (2007) (72)
- Prognosis of thick cutaneous melanoma. (1999) (71)
- Melanoma, version 4.2014. (2014) (71)
- Treatment of resectable gastric cancer (2012) (70)
- Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor (2013) (70)
- Does the Extent of Operation Influence the Prognosis in Patients With Melanoma Metastatic to Inguinal Nodes? (1999) (70)
- Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma (2010) (69)
- Early Recurrence After Lymphatic Mapping and Sentinel Node Biopsy in Patients With Primary Extremity Melanoma: A Comparison With Elective Lymph Node Dissection (2001) (69)
- Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery (2002) (69)
- Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma (2008) (69)
- Morbidity after Total Gastrectomy: Analysis of 238 Patients. (2015) (69)
- The surgical management of metastatic melanoma (2002) (68)
- Value of Frozen-Section Analysis of Sentinel Lymph Nodes for Primary Cutaneous Malignant Melanoma (2002) (67)
- Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. (2006) (66)
- Transcutaneously Tunneled Central Venous Lines in Cancer Patients: An Analysis of Device-Related Morbidity Factors Based on Prospective Data Collection (2000) (66)
- A prospective observational study examining quality of life in patients with malignant gastric outlet obstruction. (2009) (65)
- Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? (2005) (64)
- Melanoma, version 2.2013: featured updates to the NCCN guidelines. (2013) (64)
- A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. (1991) (62)
- Methods of Detection of First Recurrence in Patients with Stage I/II Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy (2008) (62)
- Sentinel lymph node biopsy for cutaneous head and neck melanomas. (2002) (61)
- Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. (2007) (61)
- Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma (2015) (61)
- Observation After a Positive Sentinel Lymph Node Biopsy in Patients with Melanoma (2014) (60)
- Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. (2005) (59)
- Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients (2010) (59)
- Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy (2017) (59)
- A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma (2007) (58)
- Role of surgery in patients with stage IV melanoma (2004) (58)
- Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. (1992) (58)
- Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer (2013) (56)
- High-pressure gradients generated by closed-suction surgical drainage systems. (2002) (56)
- Computed tomography in evaluation of patients with stage III melanoma (1997) (56)
- Neoadjuvant therapy of locally advanced gastric cancer (2010) (55)
- Surgical management of melanoma of the gallbladder: a report of 13 cases and review of the literature. (2007) (54)
- The New American Joint Committee on Cancer/International Union Against Cancer Staging System for Adenocarcinoma of the Stomach: Increased Complexity without Clear Improvement in Predictive Accuracy (2012) (54)
- Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma (2007) (53)
- Is Gastric Cancer Different in Korea and the United States? Impact of Tumor Location on Prognosis (2014) (53)
- Patterns and Predictors of Weight Loss After Gastrectomy for Cancer (2016) (52)
- Optimal Management of Gastric Cancer: Results From an International RAND/UCLA Expert Panel (2014) (52)
- A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. (2006) (50)
- Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients (2008) (50)
- Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2016) (49)
- Treatment and Outcome of Patients with Gastric Remnant Cancer After Resection for Peptic Ulcer Disease (2011) (49)
- Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. (2003) (49)
- Yield and Predictors of Radiologic Studies for Identifying Distant Metastases in Melanoma Patients with a Positive Sentinel Lymph Node Biopsy (2007) (48)
- Sentinel lymph node analysis in patients with sweat gland carcinoma (2003) (47)
- Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference (2015) (47)
- Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy (2007) (47)
- Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras (2019) (46)
- Initial experience with hand-assisted laparoscopic distal pancreatectomy (2005) (46)
- Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer (2012) (46)
- Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. (2013) (45)
- Role of surgery for metastatic malignant melanoma: a review. (1993) (45)
- NCCN Guidelines Insights: Melanoma, Version 3.2016. (2016) (45)
- Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. (2020) (45)
- Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction (2008) (44)
- Prognosis of thick cutaneous melanoma of the trunk and extremity. (1990) (44)
- Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients (2017) (43)
- Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma (2013) (43)
- Outcome of Patients with Known Metastatic Gastric Cancer Undergoing Resection with Therapeutic Intent (2007) (42)
- The Role of Sentinel Lymph Node Biopsy in the Management of Head and Neck Desmoplastic Melanoma (2012) (41)
- Internal hernia after gastrectomy for cancer with Roux-Y reconstruction. (2013) (41)
- G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma (2009) (41)
- Accurate Lymph Node Staging is of Greater Prognostic Importance Than Subclassification of the T2 Category for Gastric Adenocarcinoma (2003) (39)
- Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. (2014) (38)
- Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients (2017) (37)
- Symptoms and signs of primary melanoma (2003) (37)
- The Enigma of Regional Lymph Nodes in Melanoma. (2017) (36)
- Comparison of disease‐specific survival in the United States and Korea after resection for early‐stage node‐negative gastric carcinoma (2013) (36)
- The Challenge of Defining Guidelines for Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanomas (2012) (35)
- Assessment of Cancer Cell Line Representativeness using Microarrays for Merkel Cell Carcinoma (2014) (35)
- Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade (2019) (34)
- Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study. (2020) (34)
- Melanoma. Clinical practice guidelines in oncology. (2004) (34)
- Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype (2019) (34)
- Role of elective lymph node dissection in melanoma. (1998) (34)
- Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection (2009) (32)
- The role of surgery for patients with metastatic melanoma (2002) (30)
- NCCN melanoma practice guidelines. National Comprehensive Cancer Network. (1998) (30)
- A phase II study of preoperative chemotherapy with irinotecan(CPT) and cisplatin(CIS) for gastric cancer(NCI 5917): FDG-PET/CT predicts patient outcome (2007) (30)
- Roux-en-Y reconstruction after pancreaticoduodenectomy. (2008) (30)
- Comparison of 18F-FDG PET/CT and 111In Pentetreotide Scan for Detection of Merkel Cell Carcinoma (2011) (30)
- Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland (2016) (30)
- Neoadjuvant relatlimab and nivolumab in resectable melanoma (2022) (29)
- Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis. (2020) (29)
- Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. (2010) (29)
- Hyperthermic isolation limb perfusion for malignant melanoma: a review. (1992) (29)
- Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. (2014) (28)
- Evidence-based follow-up for the patient with melanoma. (2011) (28)
- Prognostic Significance of Targetable Angiogenic and Growth Factors in Patients Undergoing Resection for Gastric and Gastroesophageal Junction Cancers (2014) (28)
- Indications for and efficacy of splenectomy for haematological disorders (2013) (28)
- Extraneural cysticercosis presenting as a tumor in a seronegative patient. (1992) (27)
- Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma (2017) (27)
- Progress in the management of melanoma in 2013. (2013) (27)
- Role of Repeat Staging Laparoscopy in Locoregionally Advanced Gastric or Gastroesophageal Cancer after Neoadjuvant Therapy (2013) (26)
- RT-PCR Increases Detection of Submicroscopic Peritoneal Metastases in Gastric Cancer and Has Prognostic Significance (2011) (26)
- The “True” Sentinel Lymph Node: In Search of an Operational Definition of a Biological Phenomenon (2001) (25)
- Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. (2014) (25)
- PET Scanning with (18)F 2-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Melanoma. Benefits and Limitations. (1999) (25)
- Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma (2015) (24)
- Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer. (2006) (24)
- Measurement and Interpretation of Patient-Reported Outcomes in Surgery: An Opportunity for Improvement (2011) (23)
- Comparison of Young Patients with Gastric Cancer in the United States and China (2017) (23)
- An Increased Number of Sentinel Lymph Nodes Is Associated with Advanced Breslow Depth and Lymphovascular Invasion in Patients with Primary Melanoma (2009) (22)
- Melanoma. A multidisciplinary approach for the general surgeon. (2000) (22)
- Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma (2019) (22)
- Society of Surgical Oncology practice guidelines. Melanoma surgical practice guidelines. (1997) (21)
- NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019. (2020) (21)
- Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned? (2001) (20)
- Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield (2015) (20)
- Detection of Micrometastases in Peritoneal Washings of Pancreatic Cancer Patients by the Reverse Transcriptase Polymerase Chain Reaction (2007) (20)
- Risk factors for recurrence in T1‐2N0 gastric cancer in the United States and China (2016) (20)
- Radiation versus resection for Merkel cell carcinoma (2010) (19)
- Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. (2020) (19)
- Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease. (2019) (19)
- Peritoneovenous shunting for nongynecologic malignant ascites (2001) (19)
- Factors Associated With Inconsistent Sun Protection in First-Degree Relatives of Melanoma Survivors (2012) (19)
- Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. (1999) (18)
- The Prognostic Impact of Isolated Tumor Cells in Lymph Nodes of T2N0 Gastric Cancer: Comparison of American and Japanese Gastric Cancer Patients (2009) (18)
- A safe technique for the placement of implantable vascular access devices in patients with thrombocytopenia. (1988) (17)
- Prospective Evaluation of Laparoscopic Celiac Plexus Block in Patients with Unresectable Pancreatic Adenocarcinoma (2011) (17)
- A peripheral blood biomarker estimates probability of survival: the neutrophil-lymphocyte ratio in noncancer patients. (2016) (17)
- Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma (2007) (17)
- Melanoma: Clinical practice guidelines in oncology™ (2006) (16)
- Comparison of gastric cancer survival after R0 resection in the US and China (2018) (16)
- Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer: Association with Pathology and Outcome (2017) (16)
- Perineural Invasion After Preoperative Chemotherapy Predicts Poor Survival in Patients With Locally Advanced Gastric Cancer: Gene Expression Analysis With Pathologic Validation (2009) (16)
- Long‐term vascular access via the inferior vena cava (1991) (16)
- Extent of Groin Dissection for Melanoma (1992) (15)
- Splenectomy to treat splenic lesions: An analysis of 148 cases at a cancer center (2013) (15)
- Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. (2012) (15)
- Estimates of stage‐specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma (2006) (15)
- Prognostic Factors in Patients with Melanoma Metastatic to Regional Nodes (1992) (15)
- CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5’ Splice Site (2016) (15)
- Prospective impact of tumor grade assessment in biopsies on tumor stage and prognostic grouping in gastroesophageal adenocarcinoma (2012) (15)
- Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression (2007) (15)
- Detection of gastric cancer peritoneal metastases by peritoneal lavage: Current limitations and future perspectives. (2012) (14)
- Eruptive melanotic macules and papules associated with adenocarcinoma (2003) (14)
- Transected thin melanoma: Implications for sentinel lymph node staging (2018) (13)
- Cutaneous Melanoma , Version 2 . 2019 (2019) (13)
- Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas (2021) (13)
- Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors (2018) (13)
- Comparison of Long- and Short-term Outcomes in 845 Open and Minimally Invasive Gastrectomies for Gastric Cancer in the United States (2021) (13)
- What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. (2013) (12)
- Randomized, placebo-controlled trial of dietary supplementation of α-tocopherol on mutagen sensitivity levels in melanoma patients: a pilot trial (2002) (12)
- Long term central vascular access through the gonadal vein. (1992) (12)
- International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin (2014) (12)
- Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer (2016) (12)
- Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. (2016) (12)
- Global Forum of Cancer Surgeons: Declaration of Intent (2017) (11)
- Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers. (2018) (11)
- Updates on Surgical Management of Advanced Gastric Cancer: New Evidence and Trends. Insights from the First International Course on Upper Gastrointestinal Surgery—Varese (Italy), December 2, 2011 (2013) (11)
- Predicting the development of brain metastases in patients with local/regional melanoma (2014) (11)
- Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma. (2014) (11)
- Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer (2016) (11)
- Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer (2020) (10)
- Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost (2019) (10)
- Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence (2021) (10)
- Staging work-up and post-treatment surveillance of patients with melanoma. (2000) (10)
- Estimating the relative risk of developing melanoma in INK4A carriers (2004) (9)
- Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis. (2015) (9)
- The Search for Level I Evidence in Solid-Tumor Oncology (2001) (9)
- Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data Speak (2014) (9)
- 2015 James Ewing Lecture: 75-Year History of the Society of Surgical Oncology—Part III: The Transformative Years (1991–2015) (2016) (9)
- Isolation limb perfusion for melanoma: current trends and future directions. (1994) (9)
- Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma (2020) (8)
- The detection of micrometastases in melanoma sentinel nodes by step-sectioning and immunohistochemical staining: 435 (1997) (8)
- Focal nodular hyperplasia of the liver. (1990) (8)
- Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer (2021) (8)
- 2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology—Part I: The Traditional Years (1940–1965) (2015) (8)
- Controversies in the surgical management of gastric cancer. (2003) (8)
- 2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology—Part II: The Transitional Years (1966–1990) (2015) (8)
- Juvenile polyposis syndrome presenting with familial gastric cancer and massive gastric polyposis. (2012) (8)
- Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation (2017) (8)
- Surgical Oncology Fellowship: Viable Pathway to Academic Surgery? (1999) (8)
- Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone. (2016) (8)
- NCCN Guidelines and Quality Cancer Care: Where Have We Come From, and Where Should We Be Going? (2016) (8)
- Lymphatic Mapping in the Management of Melanoma in Children (1998) (7)
- Adjuvant therapy of malignant melanoma. (1997) (7)
- Clinical aspects of sentinel lymph node biopsy in melanoma. (2008) (7)
- Lymphatic mapping in the management of the patient with cutaneous melanoma (1997) (7)
- Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. (2012) (7)
- Patient-derived xenografts as models for the identification of predictive biomarkers in esophagogastric cancer. (2014) (7)
- Operative Surgical Education: Results of a Society of Surgical Oncology Fellowship Survey and Proposal for an Operative Database (2004) (7)
- External biliary duodenal drainage through a percutaneous endoscopic duodenostomy. (1989) (5)
- The role of surgery in cutaneous malignant melanoma. (1993) (5)
- Perforation of the bowel by suction drains. (1993) (5)
- Randomized, placebo-controlled pilot trial of the effects of &agr;-tocopherol supplementation on levels of autoantibodies against 5-hydroxymethyl-2-deoxyuridine in melanoma patients (2004) (5)
- Cost-Benefit Implication of Gene Expression Profiling and Adjuvant Therapy in Stage IIIA Melanoma. (2020) (5)
- Is pediatric melanoma always malignant? (2013) (5)
- Hyperthermic isolation limb perfusion (HILP) with cisplatin (CDDP) for metastatic intransit melanoma: a phase I-II trial (1993) (4)
- Pancreatic neuroendocrine tumors: Can the WHO staging system be simplified (2007) (4)
- Regional Chemotherapy of Melanoma (2000) (4)
- Metastatic squamous cell carcinoma of known and unknown primary origin treated with axillary or inguinal lymphadenectomy. (2018) (4)
- A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer (2013) (4)
- Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma (2017) (3)
- Estimating survival probability in stage III melanoma: A multivariable individualized patient risk assessment nomogram. (2006) (3)
- A Novel Microbiome Signature in Gastric Cancer (2022) (3)
- Randomized clinical trials in gastric cancer. (2010) (3)
- Association between smoking history and disease-free and overall survival in resected gastric cancer. (2010) (3)
- Gene Expression Profile-Based Risk Modeling to Select Patients With Melanoma Who Can Avoid Sentinel Lymph Node Biopsy: Are We There Yet? (2020) (3)
- Metastatic melanoma at distant sites: follow-up (2003) (3)
- Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion. (1995) (3)
- Performance of the American College of Surgeons NSQIP Surgical Risk Calculator for Total Gastrectomy. (2020) (3)
- Risk of Lymph Node Metastasis in T1b Gastric Cancer (2021) (3)
- Primary peritoneal mesothelioma: How aggressive should we be? (2004) (3)
- Underuse of staging laparoscopy for gastric cancer results in a high rate of futile laparotomy in the USA (2010) (2)
- Adjuvant therapy for gastric cancer. (2007) (2)
- Evaluation of PET response to neoadjuvant therapy for patients with gastric and GEJ adenocarcinoma. (2014) (2)
- Randomized clinical trials in melanoma. (2002) (2)
- An Overview of Adenocarcinoma of the Small Intestine (1997) (2)
- Analysis of sentinel lymph nodes in melanoma: technique versus rationale. (2006) (2)
- MelMART Trial: It’s Now or Never (2018) (2)
- International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study (2022) (2)
- In-Transit Recurrence After Sentinel Lymph NodeBiopsy in Melanoma: Primum Non Nocere (2005) (2)
- Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts (2022) (2)
- Observation after a positive sentinel lymph node biopsy in patients with melanoma. (2013) (2)
- Current management of malignant melanoma. (1993) (2)
- Direct observation of surgical wound infections at a comprehensive cancer center (1993) (2)
- Validation of the Memorial Sloan Kettering Gastric Cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time? (2022) (2)
- Risk prediction model of peritoneal seeding in advanced gastric cancer: A decision tool for diagnostic laparoscopy. (2022) (1)
- Reply to “Totally Laparoscopic Gastrectomy: A Reality for USA and Europe?” (ASO-2009-04-0501.R1) (2009) (1)
- Surgery for patients receiving ipilimumab: Safety profile and immunological insights. (2012) (1)
- Total neoadjuvant chemo (ctx; TNT) for locally advanced gastric cancer (GC): The Memorial Sloan Kettering Cancer Center experience. (2019) (1)
- Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy (2022) (1)
- Reply to "Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients With Resectable Gastroesophageal Junction and Gastric Cancer". (2017) (1)
- Merkel cell carcinoma : Improved outcome with the addition of adjuvant therapy. Authors' replay (2005) (1)
- Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma (2004) (1)
- Prospective assessment of short-term quality of life after total, distal or proximal gastrectomy for gastric cancer (2007) (1)
- Society of Surgical Oncology Presidential Address: Seattle, WA, USA, March 17, 2017 (2017) (1)
- Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma. (2013) (1)
- Phase II Trial Evaluating Esophageal Anastomotic Reinforcement with a Biologic, Degradable, Extracellular Matrix after Total Gastrectomy and Esophagectomy. (2022) (1)
- A prospective study of 18FDG-pet scanning in preoperative melanoma patients. (2004) (1)
- Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma. (2021) (1)
- MelanomaPractice Guidelines in Oncology (2012) (1)
- Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma (2023) (1)
- Appropriate Treatment for Patients with Gastric Adenocarcinoma (2008) (1)
- Trends in Completion Lymph Node Dissection for Patients with Melanoma. (2020) (1)
- Clinical and molecular characteristics of early-onset versus average-onset esophagogastric cancer. (2021) (1)
- Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma (2022) (1)
- Palliation for Malignant Gastric Outlet Obstruction: A Prospective Quality of Life Study (2008) (1)
- Surgical approaches to invasive adenocarcinoma of the gastroesophageal junction. (2013) (1)
- Is a “Merkel” Just Like a Melanoma? The Pathologic Analysis of Merkel Cell Carcinoma Specimens (2012) (1)
- Phase II trial of neoadjuvant temozolomide in advanced melanoma (2008) (1)
- Predictive value of peritoneal cytology in patients with gastric carcinoma undergoing a curative resection (2004) (1)
- Prognostic F actors A nalysis o f 1 7,600 M elanoma P atients: Validation o f t he A merican J oint C ommittee o n C ancer Melanoma S taging S ystem (2001) (1)
- Commentary (Coit)—Adjuvant Therapy for Gastric Carcinoma: Closing out the Century (1999) (0)
- Cost-Effectiveness of Adjuvant Therapy for Stage IIIA Melanoma Is Poor Even When Patients Are Risk-Stratified by Gene Expression Profile (2019) (0)
- Differences in genomic profiles of gastric adenocarcinoma in the US and Japan. (2023) (0)
- Preoperative serum VEGF-A levels to predict survival for Caucasian and Asian patients undergoing resection for gastric adenocarcinoma. (2015) (0)
- Preoperative Evaluation for Extent of Disease Complete history Sun exposure Prior moles Nonmelanoma skin cancers Family history of melanoma Examination Complete dermatologic examination Regional and remote lymph nodes Regional and remote soft tissue Laboratory studies (2017) (0)
- Pretreatment neutrophil to lymphocyte ratio as an independent predictor of disease-specific survival in resectable GE junction and gastric adenocarcinoma. (2014) (0)
- Abstract B03: Molecular profiling of immune activation associated with melanoma regression induced by diphencyprone (2015) (0)
- PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria. (2020) (0)
- Neutrophil to lymphocyte ratio to predict outcome during ipilimumab treatment. (2016) (0)
- Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection (2021) (0)
- In Reply (2003) (0)
- Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma. (2018) (0)
- Stage specific survival is altered by the changes in the 2002 AJCC staging for melanoma (2005) (0)
- The effect of preoperative chemotherapy on lymph node yield in gastric cancer. (2011) (0)
- Evaluation of the effects of neoadjuvant therapy on stage specific outcome estimates in patients with completely resected gastric cancer. (2016) (0)
- Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC). (2011) (0)
- Role of Sentinel Node Biopsy in the Management of Malignant Melanoma (2017) (0)
- – BONE AND SOFT TISSUE SARCOMAS Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2019) (0)
- NCCN Melanoma Clinical Practice Guidelines in Oncology (2012) (0)
- The Changing Kinetics of Advanced Melanoma. (2019) (0)
- Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma. (2004) (0)
- Abstract 119: Genomic analysis of remnant gastric adenocarcinoma (2016) (0)
- Are There Curative Options to Peritoneal Carcinomatosis (2005) (0)
- Response to the Letter to the Editor by CM den Bakker and DL van Der Peet. (2018) (0)
- Internal Hernia After Gastrectomy With Roux-Y Reconstruction for Cancer (2013) (0)
- Mo1734 Resected Splenic Masses Discovered on Imaging Are Frequently Malignant: A Review of 148 Cases (2013) (0)
- Follow-up of the melanoma patient: 079 (1997) (0)
- A Transplant Perspective on ‘Non-Resectable’ Soft Tissue Tumors at the Root of the Mesentery – Procedures, Promise and Pitfalls! (2011) (0)
- A simple modification of closed suction drainage systems. (1989) (0)
- Somatic mutational profile of Merkel cell carcinoma treated with immune checkpoint blockade: Preliminary results from a planned multiplatform analysis. (2019) (0)
- Training a new generation of surgeons worldwide who are also oncologists. (2016) (0)
- PD-0570 NOMOGRAM PREDICTING SURVIVAL AFTER R0 GASTRECTOMY: VALIDATION IN PATIENTS WITH POSTOPERATIVE CHEMORADIATION (2012) (0)
- review Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference (2006) (0)
- 6633 POSTER Conditional Probability of Survival Nomogram After an R0 Resection for Gastric Cancer (2011) (0)
- Desmoplastic melanoma: A pathologically and clinically distinct form of cutaneous melanoma B (2006) (0)
- Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma (2021) (0)
- Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort of HDGC patients with and without CDH1 mutation and patients with sporadic GC (2009) (0)
- 567: FACTORS ASSOCIATED WITH THE DETECTION OF HEREDITARY DIFFUSE GASTRIC CANCER ON ENDOSCOPY IN INDIVIDUALS WITH MUTATIONS IN CDH1 (2022) (0)
- Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas. (2019) (0)
- Variable penetrance of CDH1 mutation diffuse gastric cancer: A genomic analysis. (2013) (0)
- Surgical Research Review Detection of gastric cancer peritoneal metastases by peritoneal lavage: Current limitations and future perspectives (2012) (0)
- ASO Visual Abstract: Association of Obesity with Worse Operative and Oncologic Outcomes Among Patients Undergoing Gastric Cancer Resection (2021) (0)
- Fifty years of progress in gastric cancer (2022) (0)
- Genomic characterization of a comprehensive collection of esophagogastric cancer patient-derived xenografts. (2021) (0)
- Genetic variation at MC1R, GSTT1, and GSTM1 may increase risk for melanoma (1999) (0)
- Outcomes after complete pathologic response (pCR) to neoadjuvant treatment for gastric and gastroesophageal junction (GEJ) adenocarcinoma. (2011) (0)
- Methods of detection of recurrence in patients with cutaneous melanoma. (2006) (0)
- Factors Associated with Detection of Hereditary Diffuse Gastric Cancer on Endoscopy in Individuals with Germline CDH1 Mutations. (2023) (0)
- Role of repeat staging laparoscopy in locoregionally advanced gastric cancer after completion of neoadjuvant therapy. (2012) (0)
- ASO Visual Abstract: Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma (2021) (0)
- Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center mes in 41 Patients Postsurgical Outco (2016) (0)
- Dedication to Alan N. Houghton, MD (2009) (0)
- Surgical resection of gastric cancer in New York City 2000. (2004) (0)
- Fifty years of progress in surgical oncology: Melanoma (2022) (0)
- Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma. (2022) (0)
- Establishment of esophagogastric xenografts: A model for characterizing disease heterogeneity. (2012) (0)
- Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort of HDGC patients with and without CDH1 mutation and patients with sporadic GC. (2008) (0)
- Clinical experience with atypical spitzoid tumors in patients younger than age 18: Does fluorescence in situ hybridization predict lymph node metastasis? (2012) (0)
- Long-term follow-up on the surgical treatment of upper gastrointestinal neoplasms in familial adenomatous polyposis patients (2001) (0)
- Reply to "Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients with Resectable Gastroesophageal Junction and Gastric Cancer". (2016) (0)
- Distinct Differences in Gastroesophageal Junction and Gastric Adenocarcinoma in 2194 Patients (2021) (0)
- Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma. (2013) (0)
- Distal, total and proximal gastrectomy for cancer: Role of feeding jejunostomy (1998) (0)
- 6502 ORAL Preoperative Chemotherapy Does Not Influence the Number of Evaluable Lymph Nodes in Resected Gastric Cancer (2011) (0)
- Conditional survival nomogram after an R0 resection for gastric cancer. (2011) (0)
- Waterford surgical october club and surgical section, royal academy of medicine joint surgical symposium at: Waterford regional hospital (1998) (0)
- Perioperative chemotherapy plus bevacizumab with early salvage therapy based on PET response in patients with locally advanced resectable gastric/GEJ cancer. (2010) (0)
- Models for Predicting Melanoma Outcome (2020) (0)
- Positive Peritoneal Cytology in Gastric Cancer (2011) (0)
- 702 Ex-Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield (2015) (0)
- Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy? (2023) (0)
- Mo1380 Patterns of Initial Recurrence After Curative Resection for Gastric Adenocarcinoma According to Lauren Histologic Type (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Daniel G. Coit?
Daniel G. Coit is affiliated with the following schools:
